Rax/Rx is a paired-type homeodomain-containing transcription factor that is essential for cell proliferation in the developing eye and brain. The molecular mechanisms that regulate cell proliferation by rax, however, are largely unknown. Here, we identify the high mobility group B3 gene (hmgb3) as a downstream target of Xenopus rax (Xrax/XRx1). Overexpression of Xhmgb3 results in an increase in eye and brain sizes due to promoted cell proliferation, while morpholino-oligo-mediated knock down of Xhmgb3 reduces eye and brain sizes. In addition, ChIP assays showed that Xhmgb3 is recruited around the promoter region of c-myc to enhance c-myc transcription. We also found that XOptx2 requires rax for its initial expression. Furthermore, we show that Xhmgb3 and XOptx2 are required for retinal development mainly at different developmental stages. Our findings reveal a novel aspect of progenitor cell proliferation during embryonic central nervous system (CNS) development.
Introduction
Although mechanisms of neural tissue induction at early developmental stages are well characterized, less is known about how cell proliferation is developmentally regulated in the vertebrate central nervous system (CNS) (De Robertis et al., 2000; Harland, 2000; Niehrs, 2004; Stern, 2005) . The expansion of mitotic progenitor cells is required for proper organogenesis. Loss of proliferation in animals leads to developmental defects and can cause disease. In the vertebrate CNS, neural progenitor cells undergo proliferation and subsequent differentiation, leading to a normally sized brain and eye, and to functional neurons and glial cells (Chitnis, 1999; Panchision and McKay, 2002; Temple, 2001) .
It has been reported that cell-external factors influence cell proliferation of progenitor cells in the vertebrate CNS. Neural progenitor cells acquire a positional identity within the neural plate by the action of morphogens secreted from adjacent tissues. Positional identity along the anteroposterior axis is specified by fibroblast growth factor (FGF), Wnt and retinoid family ligands, whereas the dorsoventral axis is specified by the antagonistic action of bone morphogenetic protein (BMP), transforming growth factor (TGF) β ligands and sonic hedgehog (Shh). FGF, BMP, Wnt, hedgehog and retinoic acid (RA) act also as mitogens that promote proliferation of the cells (Panchision and McKay, 2002; Temple, 2001) . On the other hand, cell-internal factors, such as transcription factors, also play an important role in neural cell proliferation and differentiation. Loss-of-function assays showed that Pax6 and Emx2 are required for proliferation as well as patterning in their respective domains of the cortex, implying that positional identity genes, induced by morphogens, may directly promote cell proliferation (Bishop et al., 2000; Estivill-Torrus et al., 2002) . In the developing eye, Optx2/Six6 and Chx10 promote progenitor cell proliferation by repressing p27 expression (Green et al., 2003; Li et al., 2002) . Six3 regulates retinal progenitor cell proliferation not Developmental Biology 291 (2006) 398 -412 www.elsevier.com/locate/ydbio by a DNA-binding mechanism but by binding to geminin (Bene et al., 2004) . It has been also reported that Six3 functions in cell proliferation by repressing p27 in the anterior neural plate (Gestri et al., 2005) . These studies imply that positional identity genes may regulate progenitor cell proliferation through common and distinct mechanisms.
On the other hand, widely expressed factors also regulate cell proliferation of neural progenitors. Sox2 plays a role in maintenance of neural progenitor cells as well as in neurogenesis in vertebrates. Sox2 is widely expressed in the developing nervous system and appears not to be involved in the specification of regional identity (Graham et al., 2003) . Id4, which is expressed widely in the developing nervous system in mice, regulates neural progenitor proliferation by controlling G1-S transition (Yun et al., 2004) . Taken together, both region specific and non-specific factors contribute to progenitor proliferation in the nervous system. However, the mechanisms for how these factors promote cell proliferation are largely unknown, and the question whether or not mechanisms of proliferation by region-specific and non-specific factors are related remains to be answered. Rax is one of the key molecules essential for cell proliferation in the anterior neural plate in vertebrates. Rax is conserved among vertebrates and invertebrates, including humans, mice, chickens, zebrafish, Medaka, surface fish, Xenopus and Drosophila. The expression of rax is observed in the prospective cephalic region in gastrula and in the optic vesicle after neural tube formation (Casarosa et al., 1997; Chen and Cepko, 2002; Deschet et al., 1999; Furukawa et al., 1997; Kimura et al., 2000; Mathers et al., 1997; Ohuchi et al., 1999; Strickler et al., 2002) . Medaka harboring mutation in Rx3 locus does not develop an optic vesicle (Loosli et al., 2001 ) and mutation of rx3 in zebrafish causes the loss of eyes (Loosli et al., 2003) . The rax null mutant mice show reduced brain size and do not develop the optic vesicle (Mathers et al., 1997) . In humans, mutations of the RAX gene are associated with anophthalmia and sclerocornea (Voronina et al., 2004) . On the other hand, rax overexpression induces cell proliferation in the retina and anterior brain in Xenopus (Andreazzoli et al., 1999 Casarosa et al., 2003; Mathers et al., 1997) . Thus, rax plays significant roles during embryonic development in vertebrates, raising the possibility that the investigation of mechanisms by which rax acts may provide us more understanding of the mechanisms of cell proliferation during embryonic development.
In this study, we report the identification of Xenopus hmgb3 (Xhmgb3) as a downstream factor of rax. HMGB3 is one of HMGB proteins (HMGB1, 2 and 3), which are nonhistone chromosomal proteins characterized by the HMG domains, A and B. The HMGB proteins bind to DNA through the HMG domains and act as architectural facilitators in the manipulation of nucleoprotein complexes. The biological roles of the HMGB3 protein during embryonic development have not been clarified. We demonstrate that overexpression of Xhmgb3 results in an increase in eye and brain sizes, and, conversely, knocking down Xhmgb3 reduces eye and brain sizes in Xenopus. In addition, we show that Xhmgb3 promotes c-myc transcription. We also demonstrate that rax is required for the initial expression of XOptx2 in Xenopus. Our results indicate that rax controls cell proliferation in the CNS by at least two pathways mediated by Xhmgb3 or XOptx2.
Materials and methods

Macroarray screen
Synthetic RNAs of rax and smad10 or water were injected into Xenopus embryos at the 4-or 8-cell stage into four animal blastomeres, followed by dissection of the animal caps at stages 8/9. Single-strand cDNAs were generated from total RNA, accompanied by labeling with [α 32 P] dCTP, then used as probes for macroarray analysis, which covers 50,000 cDNA clones from Xenopus embryos at stages 10.5, 15, and 25. The signals were detected by BAS 5000 (Fuji). The signals that were at least twice as intense as the control signals were considered positive and subjected to further analysis. The clone XL154j12 (NIBB XDB, http://xenopus.nibb.ac.jp) which encodes for Xenopus hmgb3 protein was obtained. This macroarray is described in a book written by S.F. Gilbert (2003) . GenBank accession number of Xhmgb3b is AY652624.
Xenopus embryos
Embryos were obtained from Xenopus laevis adult frog by hormone-induced egg laying, in vitro fertilized using standard methods and dejellied (2% cysteine in water, pH 7.5-8.0). Embryos were staged according to Nieuwkoop and Faber (1994) . Injected embryos were raised at 15°C.
RNA microinjection, RNA synthesis and morpholino oligos
Capped RNAs were synthesized using the mMESSAGE mMACHINE kit (Ambion). Four animal blastomeres of 4-or 8-cell stage embryos were injected with capped, synthetic RNA for animal cap dissection. Injections of synthetic RNA were performed with 60 pg/blastomere of rax, with 1 ng/blastomere of smad10, with 200 pg/blastomere of rax-EnR, with 225 pg/blastomere of Xhmgb3, with 450 or 750 pg/blastomere of Xhmgb3 (contains a seven nucleotide mutation within the MO target sequence for rescue experiments), with 300 pg/ blastomere of 6x myc-tagged Xhmgb3 (6x myc-Xhmgb3) or 6x myc tag, and with 75 pg/blastomere of β-galactosidase. pCS2+ rax-EnR was generated according to a previous report (Andreazzoli et al., 1999) . pCS2+ XOptx2 and pCS2+ XOptx2HD-VP16 were provided by Drs. W.A. Harris and M.E. Zuber. pCS2+ smad10 was provided by Dr. J.M. Graff. Xenopus rax/Rx1 cDNA including the entire coding sequence was obtained by RT-PCR with primers (F), 5′-CCG-GATCCTCGTGATTGAACACCTCAGGGTCC-3′ and (R), 5′-CCGAATTCG GCTGCCCTGAGCCGTATTCATATG-3′, sequenced and subcloned into the pCS2+.
cDNAs encoding for Xhmgb3, 6x-myc tag, 6x-myc-Xhmgb3 and GFP were subcloned into pCS2+ (Gift from Dr. J.M. Graff). Antisense morpholinooligonucleotides (MOs) were purchased from Gene Tools (Philomath, USA). Sequences of MOs are as follows: Xhmgb3 MO, 5′-CTTCTTAGGGTCACGTT-TAGCCATC-3′, control MO, 5′-CCTCTTACCTCA GTTACAATTTATA-3′. The sequence of MO against Xenopus rax/Rx1 is as previously described and it was shown that the effect of rax-EnR and MO against rax/Rx1 was rescued by rax/Rx1 overexpression . MOs were injected in the amount of 1 pmol (Xhmgb3 MO and control MO) or 0.5-1 pmol (rax MO). For rescue experiments an Xhmgb3 gene that has seven mutations of nucleotides in the target region of Xhmgb3 MO was used. Xhmgb3b MO has only a one base pair substitution in the sequence of Xhmgb3a. We performed control experiments by injecting a control MO (Kinoshita et al., 2003) for all of the MO injection experiments in this study and confirmed that the control MO did not affect the expression of all genes we assessed in this study (data not shown).
Animal cap dissections
Animal caps were dissected from stages 8/9 embryos in 0.5× MMR (Marc's Modified Ringer's solution) and were incubated until sibling embryos reached stage 25 and then subjected to further analysis. Total RNA was purified using TRIzol (Invitrogen).
X-gal staining, in situ hybridization, and Northern hybridization Embryos were grown to the desired stage, devitellinized and fixed in MEMFA for 30 min followed by a brief wash in PBS and transferred into the Xgal staining solution until staining was apparent. Whole mount in situ hybridization was performed essentially as described (Harland, 1991) using digoxygenin-labeled antisense RNA probes. Section in situ hybridization was performed essentially as described (Dorsky et al., 1995) with minor modification. Cryosections of retina at stages 40/41 were used. The substrate for the chromogenic reaction was NBT/BCIP. Northern hybridization was performed as described previously (Furukawa et al., 1997) .
Quantification of enlarged eye
Embryos injected with Xhmgb3 + β-gal RNAs or only β-gal RNA were grown to stages 37/38 and fixed in MEMFA at room temperature for 30 min, followed by the X-gal staining. The epidermis overlaying the eye was removed. The eye diameters were measured and used to calculate the percent increase in eye diameter on the injected side of each embryo.
Immunohistochemistry
Immunostaining of cryosections was performed as described previously (Nishida et al., 2003) . Anti-phospho-histone H3 antibody (Upstate, #06-570), anti-β-galactosidase antibody (Promega, #Z3781), Cy3-conjugated-anti-rabbit antibody (Jackson ImmunoResearch Laboratories, #711-165-152) and Cy3-conjugated-anti-mouse antibody (Jackson ImmunoResearch Laboratories, #711-165-150) were used at concentrations of 10 μg/ml, 2.3 μg/ml, 7.5 μg/ml, and 7 μg/ml, respectively.
Quantification of anti-phospho-histone H3 antibody positive cells
Cryosections (12 μm) from embryos injected with only β-gal RNA or Xhmgb3 + β-gal RNAs were subjected to an immunostaining with an anti-β-gal antibody or an anti-phospho-histone H3 antibody. Among sections obtained from each embryo, one section was subjected to an anti-β-gal antibody to confirm the injected side. Positive cells were counted under fluorescence microscopy. The sum of the number of positive cells on the sections derived from one embryo was the number of positive cells in the whole left or right eye. The ratio of the number of positive cells in an injected eye to the number of positive cells in an un-injected eye was calculated for each embryo.
In vivo lipofection
DNA was lipofected into the anterior neural fold of stage 18 embryos as previously described (Holt et al., 1990; Dorsky et al., 1995) . GFP DNA was colipofected to mark the lipofected cells. Embryos were fixed at stage 41, sectioned on a cryostat at a thickness of 10 μm. GFP-positive cells were counted and the cell type identified based upon their laminar position and morphology as previously described (Dorsky et al., 1995 (Dorsky et al., , 1997 .
Detection of apoptotic cells
Embryos were harvested at stages 31/32 and fixed in MEMFA at room temperature for 20 min. Cryosections (14 μm) were made from embryos and subjected to a TUNEL (TdT-mediated dUTP Nick-End Labeling) assay. The TUNEL assay was performed according to the instruction manual protocol (Promega). Similar results were obtained on several sections in at least two independent experiments.
Chromatin immunoprecipitation (ChIP)
About fifty animal caps were isolated at stages 8/9 from embryos injected with the appropriate synthetic RNA, and crosslinked with 1% formaldehyde at room temperature for 20 min. After rinsing with ice-cold PBS, animal caps were incubated in 0.125 M glycine for 10 min at room temperature and followed by the steps described previously (Takebayashi-Suzuki et al., 2003) with minor modifications. The immunocomplexes were eluted with elution buffer (50 mM Tris, pH 8.0, 1 mM EDTA and 1% SDS) at 65°C for 20 min. For IP an anti-myc antibody (Santa Cruz #sc-40) was used. Primer sequences are as follows: for Primer-set 2, (F) 5′-GTACGAGCCACACACGGAGTTGG-3′ and (R) 5′-GCTCCGACTGAGCCTTATA TAGC-3′; Primer-set 1, (F) 5′-ATGTAATGTA-TAAGAATTGAGC-3′ and (R) 5′-AAAGGGCACATTCACAAGCAGATATG-3′; Primer-set-coding, (F) 5′-CCCACTAC AGCCCTTTAGTTCTG-3′ and (R) 5′-TCTGGCGCTCCAGAACGTTG-3′. 28 cycles of amplification were used for PCR.
Probes for hybridization and primers for RT-PCR
The probes used for hybridization (in situ hybridization and Northern hybridization) of rax, Xhmgb3, Xhmgb3a and XOptx2 were the entire proteincoding region of each. Probes for hybridization were obtained by RT-PCR. Primers for RT-PCR were as followed, Xenopus Pax6, forward (F) 5′-CAACCTGGCGAGCGATAAGC-3′ and reverse (R) 5′-GTGTATGTGTCATA-GCTCCG-3′; for Xenopus Six3, (F) 5′-CCAACTT CCCCATGGTGTTCAGGT-CCCCTC-3′ and (R) 5′-GTCCATAG GAGCCCTGATCTG CCTGGGTCC-3′; for Xenopus c-myc, (F) 5′-AGCCTTGC TGAAGTCCATCG-3′ and (R) 5′-TCTGGCGCTCCAGAACGTTG-3′; for Xenopus N-myc, (F) 5′-TTTGAC-TCCCTGCAACCTTGT-3′ and (R) 5′-CTGCAATTCCTAGCTGTCGTG-3′; for Xenopus engrailed (En) 2, (F) 5′-GGAAGTGGAGCCACAGCAGG-3′ and (R) 5′-AGCAGTGA AGGCAGTTCTGG-3′. The cDNA fragments obtained were subcloned into pGEM-T-easy (Promega) and sequenced.
Results
Induction of Xhmgb3 by rax overexpression
To investigate the molecular mechanisms of progenitor cell proliferation in the developing CNS, we attempted to identify the downstream mediators of rax using the Xenopus animal cap assay. Rax can induce transcription factors that are expressed in the eye field such as Pax6 and XOptx2 in animal caps . However, overexpression of rax could not induce ectopic eye formation, although rax can induce ectopic retinal pigmented epithelium (RPE) (Mathers et al., 1997) , suggesting that rax alone could not induce downstream factors efficiently C and D) or Xhmgb3a (E) by rax MO injection. Northern blot analysis of total RNA isolated from animal caps injected with water, rax or rax + smad10 RNAs. The cDNA fragment encoding for entire protein of Xhmgb3 was used as a labeled probe (A). The lower panel shows Ethidium Bromide (EtBr) staining of ribosomal RNA (A). In situ hybridization using a probe of Xhmgb3 for embryos injected with rax and β-gal RNAs (stages 18/19) (B) or rax MO (1 pmol) and β-gal RNA (stages 17/18) (C) into one dorsal blastomere at 4-or 8-cell stage on the animal side. Anterior view with dorsal to the top (B) or anterior-dorsal view (C). Section in situ hybridization using a probe of Xhmgb3 (D) or Xhmgb3a (E) followed by immunostaining against β-gal for embryos injected with rax MO (0.5 pmol) and β-gal RNA. The injected side or areas are indicated by β-gal activity in blue (B and C) or by β-gal immunostaining in red (D and E) and also indicated by green arrows (B, D and E) . White brackets at both sides of midline indicate the anterior expression of Xhmgb3 in rax MO-injected and control side (C). in animal caps. Rax is expressed in the neural plate, suggesting that rax is able to efficiently act in the neural tissue (Casarosa et al., 1997; Mathers et al., 1997) . Recently, Xp53 was identified as a posteriorizing factor that acts efficiently after neural induction by noggin in animal caps (Takebayashi-Suzuki et al., 2003) . Similarly, we co-injected synthetic RNAs of rax (rax RNA) and smad10 (smad10 RNA), which induces neural tissue in Xenopus ( LeSueur and Graff, 1999; LeSueur et al., 2002) , speculating that rax could induce downstream genes efficiently with smad10 in animal caps. We then performed a differential screen using a Xenopus macroarray. We prepared probes for macroarray screening from animal caps that either had or had not been injected with rax and smad10 RNAs. We speculated that genes induced by rax would be mainly expressed in the anterior neural plate and in the optic vesicle. We identified four genes, which showed relatively similar expression patterns to that of rax. Subsequently, we examined whether those genes are induced in animal caps by rax alone using Northern hybridization. We found that one gene, which encodes a high mobility group b (hmgb) protein, was induced by rax alone in animal caps (Fig. 1A) . Next, we examined whether rax RNA, together with β-galactosidase (β-gal) RNA (75 pg) as a tracer, can induce Xhmgb3 expression in Xenopus embryos to exclude that Xhmgb3 is downstream of smad10 alone. Xhmgb3 expression was enhanced upon rax injection in Xenopus embryos (34%, n = 41) (Fig. 1B) , while knock down of rax by an antisense morpholino-oligo against rax (rax MO, 1 pmol) reduced Xhmgb3 expression in Xenopus embryos (32%, n = 31) (Fig. 1C) . We then examined whether rax also regulates Xhmgb3 expression in the brain because rax is expressed in the prospective forebrain before neural tube formation. We found rax MO (0.5 pmol) reduced Xhmgb3 expression on the injected side (100%, n = 4) (Fig. 1D) , suggesting that the action of rax in the neural plate is required for normal expression of Xhmgb3.
Xenopus laevis is a functional diploid, but most of the genes are present in two copies as a result of its allotetraploid origin (Graf and Kobel, 1991) . We found a Xenopus hmgb3, which has high homology with the gene we identified (91% identical in nucleic acid sequence), in the database (GenBank accession number: BC044009). Therefore, we referred to the gene we identified as Xhmgb3b and to the gene in the datebase as Xhmgb3a in this manuscript. In this report, all mentions of Xhmgb3 will refer to Xhmgb3b.
Developmental expression of Xhmgb3
Xhmgb3 is expressed in the entire animal sphere at stage 10.5 (Fig. 1F) . At stage 12.5, Xhmgb3 mRNA is expressed across the whole neural plate, however, it is strongly expressed in the anterior region (Fig. 1G) . At stage 15, the Xhmgb3 expression increased significantly in the anterior part of the neural plate (Fig. 1H) . At stages 18/19 (Fig. 1I) , Xhmgb3 expression was observed in the entire central nervous system and at stage 25, strong signal was detected in the optic vesicle (Fig. 1J) . At later stages, Xhmgb3 expression was observed in the forebrain, midbrain, hindbrain, otic vesicle, anterior part of the spinal cord, branchial arches and eye (Figs. 1K-M) . At stage 39, Xhmgb3 expression decreased significantly and the hybridization signal was barely observable (Fig. 1N) . We did not detect a significant Xhmgb3 signal at later stages by whole-mount in situ hybridization (data not shown). Xhmgb3 was expressed throughout prospective retina at stage 25 when most cells are proliferating (Fig. 1O) . Xhmgb3 expression was detected in the forebrain at stage 41 by section in situ hybridization (Fig. 1P) . We examined Xhmgb3 expression further in the retina. At stages 40 and 41, Xhmgb3 was expressed in the ciliary marginal zone (CMZ), where cell proliferation occurs throughout the animal's life (Figs. 1Q and R) . We also found that Xhmgb3a showed a similar expression pattern to that of Xhmgb3 (Figs. 1S-U) and that Xhmgb3a was regulated by rax (100%, n = 3) (Fig. 1E) , suggesting that Xhmgb3 and Xhmgb3a are redundant factors in Xenopus.
Overexpression of Xhmgb3 enlarges the eye and brain structures
To investigate the roles of Xhmgb3 during embryonic development in Xenopus, we first performed overexpression experiments. In the Xhmgb3-injected embryos, we observed an enlargement of the eye and brain structure on the injected side (Figs. 2B and C), while not in the β-gal-injected embryos ( Fig. 2A) . Some embryos showed an expansion of retinal tissue upon Xhmgb3 expression (Fig. 2D) . We quantified the effect of Xhmgb3 overexpression based on eye diameters (Figs. 2E and F) . In the embryos injected with β-gal and Xhmgb3 RNAs, the distribution of eye sizes was significantly biased toward enlarged eye classes, while that was not the case in the control embryos (Fig. 2E ). Around 50% of the embryos injected with Xhmgb3 RNA showed an increase in the diameter of the eye (Figs. 2E and F) . This phenotype was maximal in embryos injected with Xhmgb3 RNA between 225 pg and 300 pg at 4-or 8-cell stage. We did not observe any morphological abnormality of embryos that were injected with Xhmgb3 RNA into the ventral blastomere on the animal side or vegetal side of embryos at 8-cell stage by visual inspection (data not shown).
Overexpression of Xhmgb3 promotes progenitor cell proliferation in the developing retina and brain
We next examined whether Xhmgb3 promotes cell proliferation using an anti-phospho-histone H3 antibody (αPH3Ab), which detects mitotic cells. We analyzed the number of αPH3Ab positive cells in each eye (213 sections from 13 embryos injected with β-gal RNA and 263 sections from 15 embryos injected with Xhmgb3 + β-gal RNAs). We also analyzed the brain (forebrain-midbrain) (354 sections from 14 embryos injected with β-gal RNA and 337 sections from 14 embryos injected with Xhmgb3 + β-gal RNAs). The injected side was determined by anti-β-gal immunostaining (Figs. 2G and I). We observed an increase of the relative frequencies of mitotic cells in the developing retina and brain in the Xhmgb3-injected embryos (Figs. 2J-L) , while not in the β-gal RNAinjected embryos (Figs. 2H, K and L) .
We then examined whether overexpression of Xhmgb3 affects cell fate decisions of progenitor cells in the developing retina (Figs. 2M and N) . DNA was lipofected into the anterior neural fold of stage 18 embryos. GFP DNA was colipofected to mark the lipofected cells. Embryos were fixed at stage 41, sectioned on a cryostat at a thickness of 10 μm. GFP-positive cells were counted and the cell type identified based upon their laminar position and morphology as previously described . n = 506 cells from nine embryos for GFP, n = 1264 cells from eleven embryos for Xhmgb3. Data are means ± SEM. *P = 0.045 (Mann-Whitney's U test). le, lens; re, retina; rpe, retinal pigmented epithelium; ph, photoreceptor cell; bi, bipolar cell; ga, ganglion cell; am, amacrine cell; ONL, outer nuclear layer; INL, inner nuclear layer; GCL, ganglion cell layer. (Dorsky et al., 1995 (Dorsky et al., , 1997 . Proportions of observed photoreceptor cells and Müller glia were affected in the Xhmgb3-injected retina (Fig. 2N) . It appeared, however, that Xhmgb3 did not affect cell fate decisions significantly compared with other factors previously reported (Dorsky et al., 1997; Viczian et al., 2003) . These results suggest that Xhmgb3 is involved in photoreceptor production at the expense of Müller glia production, although the increase in the population of photoreceptor cells is not statistically significant (P = 0.0742).
Xhmgb3 is required for eye and brain development in Xenopus
To examine whether Xhmgb3 is required for normal Xenopus development, we performed knock down experiments using Xhmgb3 MO. Xhmgb3 MO-injected embryos showed smaller eye and brain structures (Figs. 3A-C and E), compared to the control MO-injected embryos (Fig. 3D ). An injection of Xhmgb3 MO resulted in small eyes with 74% showing a more than 50% decrease in size compared to the control eye diameter and 26% showing a less than 50% decrease in size compared to the control (n = 27, Table 1 ). We tested if co-injection of Xhmgb3 RNA could rescue the phenotype resulted from Xhmgb3 MO injection (Fig. 3F, Table 1 ). An injection of 450 pg of Xhmgb3 RNA at the 4-cell stage rescued the knock-down phenotype with 55% showing an over 50% of reduction of the eye diameter compared to the control side, 35% showing a less than 50% reduction of eye diameter compared to the control, and 10% completely rescued in eye size (n = 20). Furthermore, an injection of 750 pg of Xhmgb3 RNA at 4-cell stage rescued the knock-down phenotype more efficiently with 9% showing an over 50% of reduction of the eye diameter compared to the eyes of the control side, 39% showing a less than 50% reduction of eye diameter compared to the control side and 52%, completely rescued in eye size (n = 23). We did not observe morphological abnormalities in embryos injected with Xhmgb3 MO into the ventral blastomere on either the animal side or the vegetal side of the embryos (data not shown). These results indicate that Xhmgb3 is required for the normal eye and brain development in vivo.
Rax is required for the initial expression of XOptx2
XOptx2, a Six-family transcription factor, promotes cell proliferation in the eye field and in the developing retina in Xenopus (Zuber et al., 1999) . Since the expression of XOptx2 mRNA begins after rax expression (Zuber et al., 1999 , we investigated whether rax is required for the expression of XOptx2 by using the dominant inhibitory mutant of rax (raxEnR), in which the engrailed repressor domain is fused to rax, and rax MO (Andreazzoli et al., 1999 . Injections of rax-EnR RNA or rax MO significantly reduced XOptx2 expression (rax MO 0.5 pmol, 56% reduction, n = 16; rax MO 1 pmol, 68% reduction, n = 19; rax-EnR, 70% reduction, n = 34) (Figs. 4A, B, F and Table 2 ) and resulted in small eyes (Fig. 4I) . In contrast, they did not largely affect the An injection of Xhmgb3 MO resulted in small eyes with 74% showing a more than 50% decrease in size compared to the control eye diameter and 26% showing a less than 50% decrease in size compared to the control (n = 27). An injection of 450 pg of Xhmgb3 RNA at the 4-cell stage rescued the knock-down phenotype with 55% showing an over 50% of reduction of the eye diameter compared to the control side, 35% showing a less than 50% reduction of eye diameter compared to the control, and 10% completely rescued in eye size (n = 20). Furthermore, an injection of 750 pg of Xhmgb3 RNA at 4-cell stage rescued the knock-down phenotype more efficiently with 9% showing an over 50% of reduction of the eye diameter compared to the eyes of the control side, 39% showing a less than 50% reduction of eye diameter compared to the control side and 52%, completely rescued in eye size (n = 23).
expression of Pax6 (rax MO 0.5 pmol, 0% reduction, n = 16; rax MO 1 pmol, 13% reduction, n = 17; rax-EnR, 12% reduction, n = 25) (Figs. 4C, D and G) or Six3 (rax MO 0.5 pmol, 0% reduction, n = 19; rax-EnR, 4% reduction, n = 24) (Figs. 4E and H). These results indicate that rax is required for XOptx2 expression in Xenopus.
Roles of Xhmgb3 in eye development
Inhibition of rax function reduces eye and brain sizes mainly due to the reduced cell proliferation Casarosa et al., 2003) . We examined whether or not Xhmgb3, which we identify as a downstream target of rax, rescues the knock-down phenotype by rax MO injection. Coinjection of rax MO (1 pmol) and Xhmgb3 RNA, however, still resulted in reduced eye and brain sizes (data not shown), suggesting that other factor(s) functions downstream of rax. We then tested whether co-expression of Xhmgb3 and XOptx2 rescues the small eye phenotype. We injected 5 pg of XOptx2 RNA at 4-cell stage, since an injection of XOptx2 between 7.5 pg and 10 pg at 2-cell stage showed a maximal effect (Zuber et al., 1999) . However, XOptx2 and Xhmgb3 failed to rescue the phenotype caused by rax MO (1 pmol) (data not shown), suggesting that other molecule(s) acts downstream of rax and is required for normal development Kennedy et al., 2004) . We then reduced the amount of rax MO for injection (from 1 pmol to 0.5 pmol), leading to a partial inhibition of rax-activated pathways. Embryos injected with rax MO (0.5 pmol) showed small eyes (Fig. 4I) . We assessed the effect of Xhmgb3 and XOptx2 expression based on the eye diameters in the injected side. Xhmgb3 did not rescue the knock-down effect by rax MO (0.5 pmol) (data not shown). On the other hand, XOptx2 rescued the smaller eye phenotype caused by rax MO (0.5 pmol) (around 65% of embryos are completely rescued) (Fig.  5A ). Co-injection of Xhmgb3 + XOptx2 RNAs showed synergistic effect to rescue the knock-down phenotype by rax MO (around 80% of embryos are completely rescued) (Fig. 5A) , suggesting that Xhmgb3 may act in a different pathway from XOptx2. To test whether Xhmgb3 acts in an independent pathway to XOptx2, we performed rescue experiments by co-injection of Xhmgb3 MO and XOptx2 RNAs (Figs. 5B-I ). Embryos injected with Xhmgb3 MO + XOptx2 RNAs showed enlarged eyes similar to those of XOptx2 RNA only-injected embryos around at early tailbud stages (Figs. 5C, E and J). However, these embryos eventually resulted in small eyes at stages 37/38 (Figs. 5I and  L) , while XOptx2 only-injected embryos resulted in large eyes Xenopus embryos were injected with raxMO or raxEn RNA at 4-to 8-cell stage into one dorsal blastomere on animal side and harvested at stages 17/18. Whole mount in situ hybridization was performed with DIG-labeled antisense RNA probes for XOptx2, Pax6 or Six3. %: The percentage of embryos that showed reduced expression of genes indicated. n: The number of embryos analyzed. (Figs. 5G and K). We analyzed whether or not apoptosis occurs in the eye of the injected side. The eyes injected with XOptx2 RNA and Xhmgb3 MO appear to stop growing around stage 28 (data not shown). We detected few apoptotic cells in the retina of the un-injected side, although apoptotic cells were detected outside the retina (Fig. 5M) . In contrast, we detected apoptotic cells in the retina of the injected side, although the number of apoptotic cells was not significant (Fig. 5N) . These results suggest that Xhmgb3 may have an anti-apoptotic role other than regulation of cell proliferation. Alternatively, the reduction of Xhmgb3 activity may result in defective cell proliferation followed by cell death. In summary, these results suggest that Xhmgb3 is required for eye development not in the early developmental stages but in the late developmental stages. We next examined whether XOptx2 and Xhmgb3 stimulate each other's expression. Overexpression of XOptx2 did not affect the expression of Xhmgb3 in embryos (data not shown). We also examined that issue using animal caps and did not observe an enhancement of Xhmgb3 transcription upon XOptx2 overexpression (Fig.  5O) . Similarly, Xhmgb3 overexpression did not affect the expression of XOptx2 in Xenopus embryos (at stages 17/18, no change: 90%, reduction: 10%, n = 20; at stage 20, no change: 100%, n = 11) (Fig. 5P , data not shown) nor the transcription of XOptx2 mRNA in animal caps (data not shown). These results raise the possibility that Xhmgb3 and XOptx2 act in at least a partially independent manner.
Roles of Xhmgb3 in the early neural plate
We examined whether Xhmgb3 is required for the early eye development, including the eye field and the optic vesicle formation. We assessed the eye field development by the expression domain of rax, Pax6 and Six3. It was reported that the expansion of rax-expressing domain caused by overexpression of XOptx2 is not due to the stimulation of rax transcription but rather due to enhanced cell proliferation Zuber et al., 1999) (Fig. 6A ). An inhibition of XOptx2 by XOptx2HD-VP16 RNA injection (27 pg), which encodes a dominant inhibitory mutant of XOptx2 (Zuber et al., 1999) , reduced the eye field (rax, 72% reduction, n = 18, Fig. 6B ). In contrast, Xhmgb3 MO did not affect the eye field (rax, 0% reduction, n = 13, Fig. 6C ; Pax6, 10% reduction, n = 11, Fig. 6D ; Six3, 0% reduction, n = 11, Fig. 6E ). Overexpression of Xhmgb3 appeared to expand the eye field slightly (rax, 64% slight expansion, 6G). Similarly, overexpression of Xhmgb3 did not rescue the reduction of the eye field by XOptx2HD-VP16 (rax, 84% reduction, n = 19, Fig. 6H ). We also examined whether Xhmgb3 is required for the normal expression of XOptx2 since Xhmgb3 expression begins before XOptx2 expression. Xhmgb3 MO appeared to affect the expression of XOptx2, although slightly, (53% reduction, n = 30, Fig. 6I ), suggesting XOptx2 expression is controlled by multiple factors. This effect was rescued by co-injection of Xhmgb3 RNA with Xhmgb3 MO (9.5% reduction, n = 21, Fig. 6J ).
Since Xhmgb3 is expressed across the neural plate, we examined the roles of Xhmgb3 in regions other than the anterior neural plate. We observed that Xhmgb3 MO reduced XEn2 expression (76% reduction, n = 17, Fig. 6K ), while overexpression of Xhmgb3 rescued this effect (35% reduction, n = 20, Fig. 6L ), suggesting that Xhmgb3 is required for XEn2 expression or that Xhmgb3 is involved in the specification of the neural plate caudal to the eye field.
Xhmgb3 controls the transcription of Xenopus c-myc mRNA HMGB proteins interact with transcription factors and modulate the events of transcription (Agresti and Bianchi, 2003; Agresti et al., 2005; Bustin, 1999; Thomas and Travers, 2001; Travers, 2003) . We, therefore, investigated whether Xhmgb3 affects the transcription of cell cycle regulator genes because Xhmgb3 promotes cell proliferation. We tested various cell cycle factors and found that c-myc transcription was upregulated upon Xhmgb3 overexpression in animal caps (Fig. 7A) . c-myc is expressed in the anterior region and edge of the neural plate in Xenopus embryo (Fig.  7B) . We next examined whether Xhmgb3 is required for the expression of c-myc in vivo. C-myc expression was diminished in the Xhmgb3 MO-injected embryos (stages 13/14, 70% reduction, n = 43; stages 17/18, 27% reduction, n = 26) (Fig. 7C , data not shown), while this effect was rescued by co-injection of Xhmgb3 RNA (Fig. 7D ) (15% reduction, n = 19). We did not observe expansion of the cmyc expression domain upon Xhmgb3 overexpression (data not shown), suggesting that Xhmgb3 may affect the efficiency of c-myc transcription. We also found that the expression of N-myc was downregulated by Xhmgb3 MO injection (stages 17/18, 56% reduction, n = 25) (Fig. 7E) , while this effect was rescued by co-injection of Xhmgb3 RNA (17% reduction, n = 17) (Fig. 7F) . Furthermore, we performed a chromatin immunoprecipitation (ChIP) assay to test whether overexpressed Xhmgb3, which is fused to a 6x myc epitope-tag, is recruited around the promoter region of Xenopus c-myc gene ( Fig. 7G ; Girard-Reydet et al., 2004) . We observed that 6x myc-Xhmgb3 was recruited around the promoter region of Xenopus c-myc gene (Fig. 7I ), but we did not observe the recruitment of the only 6x myc tag (Fig.  7H) . In contrast, 6x myc-Xhmgb3 did not appear to be recruited to the coding region of Xenopus c-myc gene (Fig.  7K ) nor to the~3 kb upstream region of c-myc (Fig. 7J) . These results show that Xhmgb3 activates c-myc transcription through interacting with the c-myc promoter.
Discussion
Rax in the CNS development
It has been reported that co-expression of eye field transcription factors, including rax/Rx, Pax6, Otx2, XOptx2, Six3, Tll and ET, results in ectopic eye formation in Xenopus in high frequency . Pax6 can induce eyelike structure in Xenopus, although not efficiently, suggesting that Pax6 has an ability to induce eye cell fate in the neural plate in vertebrates (Chow et al., 1999) . XOptx2 promotes cell proliferation specific to the eye field and developing retina (Zuber et al., 1999) . Six3 can induce retinal tissue and also promotes retinal cell proliferation (Bene et al., 2004; Loosli et al., 1999; Gestri et al., 2005) . On the other hand, rax/Rx knock out mice show no optic vesicle, while Pax6 mutant mice develop the optic vesicle (Mathers et al., 1997; Hill et al., 1991) . In the Xenopus animal cap assay system, rax induces the transcription of mRNAs of Pax6 and XOptx2 , and overexpression of rax induces optic vesicle-derived tissue, RPE, in Xenopus (Mathers et al., 1997) . Thus, previous studies revealed that eye field transcription factors play their roles in a complex context. These factors transform the neural plate into the eye field and promote cell proliferation to expand the eye field, leading to the optic vesicle formation and eye development either, by activating or repressing the downstream targets, or by binding to the other factors to modulate the activity of them.
We showed inhibition of rax results in a reduction of the expression of XOptx2, whereas Pax6 and six3 were hardly affected, indicating that rax is required for the initial expression of XOptx2 in Xenopus. As for Pax6 and six3, they may not require rax function for their initial expression. This observation is consistent with the previous analysis of the Rx3 mutant of zebrafish (Loosli et al., 2003) . On the other hand, rax/Rx null mutant mice does not express Pax6 nor six3 in the location where optic vesicles are formed in wild type mice (Zhang et al., 2000) . This discrepancy may be caused by the difference of transcriptional network between species or may reflect the differences of developmental stages when we examined gene expressions.
Previous reports showed that rax induces Xhairy2A and Zic2 in the anterior neural plate in Xenopus at early stages and antagonizes neural differentiation, leading to cell proliferation in the anterior neural plate, including the eye field and prospective anterior brain . On the other hand, the existence of other pathways controlled by rax has been suggested Kennedy et al., 2004) . In this study, we showed that Xhmgb3 is controlled by rax in Xenopus. We showed that Xhmgb3 is induced by rax in both Xenopus embryos and in animal caps. The expression domain of Xhmgb3 is not confined to the expression domain of rax, as is the expression domain of Xhairy2A , and knocking down rax results in a reduction of Xhmgb3 expression, although it is not completely lost. These observations suggest that other factors may contribute to the expression of Xhmgb3 in the neural plate. In addition, we found that rax is required for the initial XOptx2 expression. These observations suggest that rax functions through at least three pathways, Xhairy2A and Zic2 pathway, Xhmgb3 pathway, and XOptx2 pathway.
How is it that rax requires at least three pathways, as described above, for cell proliferation during embryonic development in Xenopus? One possible explanation is that each pathway is required for a different stage. A previous report demonstrates that Xhairy2A and Zic2 inhibit neural differentiation in the early neural plate, leading to cell proliferation . XOptx2 promotes eye field expansion strongly, leading to the optic vesicle formation, and XOptx2 also promotes cell proliferation in the developing retina (Zuber et al., 1999) . The Xhmgb3 knock down did not affect eye field development. On the other hand, inhibition of XOptx2 reduced the eye field. Furthermore, overexpression of XOptx2 does not rescue the effect of knocking down Xhmgb3 around stages 37/ 38, although XOptx2 rescued at earlier tailbud stages, suggesting that Xhmgb3 has essential roles at later developmental stages.
Another explanation is that rax may control cell proliferation in the eye field mainly by XOptx2 and in the anterior neural plate, eye and brain mainly by Xhairy2A, Zic2 and Xhmgb3 mainly. The expression of XOptx2 is restricted to the eye field and eye, while Xhairy2A and Zic2 are expressed in the anterior neural plate. Xhmgb3 is also expressed in the neural plate in early development and subsequently throughout the entire CNS Zuber et al., 1999;  Fig. 1 ). After neural tube formation the expression of rax is restricted to the optic vesicle (Mathers et al., 1997; Casarosa et al., 1997) , whereas Xhmgb3 is expressed in the entire central nervous system. This suggests that the regulation of Xhmgb3 expression is switched, while the expression of rax in early neural plate is required for the normal expression of Xhmgb3 in the anterior part of embryos (Fig. 1D) . The observation that rax MO reduced brain size as well as eye size supports the idea that rax affects the gene expression required for the normal development in anterior brain. However, the mechanisms that determine the different expression domain of Xhariy2A, Zic2, XOptx2 and Xhmgb3 are unknown, although they appeared to be regulated by rax.
Roles of Xhmgb3 in cell proliferation
Hmgb proteins are nuclear proteins characterized by conserved HMG domain A and B, which interact with the DNA through the minor groove. Hmgb1/2 bind to DNA in a sequence non-specific manner and with low affinity to singlestranded, liner duplex and supercoiled DNA but exhibit a higher affinity for unusual DNA structures such as four-way junctions and cisplatin-modified DNA. The structures of these proteins show high homology, over 80% amino acid identity, and their biochemical properties are so far indistinguishable. It, therefore, has been suggested that recently identified hmgb3 also possesses similar biochemical properties to those of hmgb1/2 (Agresti and Bianchi, 2003; Bustin, 1999; Thomas and Travers, 2001; Travers, 2003; Vaccari et al., 1998) . However, recent studies demonstrated that biological functions of hmgb1 and hmgb2 are not completely identical (Calogero et al., 1999; Ronfani et al., 2001) .
The in vivo roles of hmgb3 during embryonic development have not been clarified. Xhmgb3 mRNA is expressed mainly in the central nervous system, including eye and brain, and its expression in the retina is restricted to the CMZ, where cell proliferation continues throughout the animal's life in amphibians at stage 40. It has been reported that the CMZ expresses factors for retinal progenitor proliferation and/or differentiation, including rax/Rx, Six3, Pax6, Cyclin D1, X-Notch-1 and bHLHs (Dorsky et al., 1997; Ohnuma et al., 2002; Perron et al., 1998) . We observed a very weak effect of Xhmgb3 on the cell fate decisions of retinal progenitor cells, implying that Xhmgb3 may have a minor function to regulate the potential of cell fates in retinal progenitor cells. The reduction of Müller cells by Xhmgb3 suggests that promoted cell proliferation by Xhmgb3 is unlikely due to the inhibition of neurogenesis. Expression of Xhmgb3 in the CMZ was observed in the peripheral region, in which retinal progenitor cells are maintained (Ohnuma et al., 2002; Perron et al., 1998) , supporting our observation that Xhmgb3 is necessary for cell proliferation in the retina of Xenopus.
Myc has been reported to be involved in the promotion of cell proliferation by controlling the expression of cyclindependent kinase CDK4 (Hermeking et al., 2000) , the Cdc25A phosphatase that activates CDKs (Galaktionov et al., 1996) , cyclin D2 (Bouchard et al., 1999; Perez-Roger et al., 1999) and E2F family (Leone et al., 2001) . Myc may further stimulate cyclin E/Cdk2 activity by directly or indirectly abrogating the function of the CDK inhibitor p27
Kip1 (O'Hagan et al., 2000; Perez-Roger et al., 1999) and by inducing the Rb antagonist Id2 (Lasorella et al., 2000) . Myc also represses genes that function to inhibit proliferation such as gadd45 (Marhin et al., 1997) , p15
Ink4b (Staller et al., 2001) , and p21 Cip1 (Gartel et al., 2001) . The reduction of c-myc levels results in reduced body mass owing to multiorgan hypoplasia in mice (Trumpp et al., 2001 ) and c-myc knock out cells showed reduced cell proliferation (de Alboran et al., 2001) . The expression of cmyc was detected by whole mount in situ hybridization only up to tailbud stages (Bellmeyer et al., 2003) , although Northern blotting detected the expression even after tailbud stages in Xenopus (Schreiber-Agus et al., 1993) . This suggests that c-myc is expressed widely in embryos at relatively low expression level after tailbud stages in Xenopus. It has been shown that cmyc knock down results in defects in cranial region, including eye and brain in Xenopus (Bellmeyer et al., 2003) . We found that Xhmgb3 directly controls c-myc transcription, suggesting Xhmgb3 contributes to cell proliferation by regulating c-myc transcription. It has been reported that the hmgb1 mRNA level is increased in tumors, including human breast carcinomas (Brezniceanu et al., 2003) . Hmgb1 has been reported to bind to the estrogen receptor and to enhance gene expression in cultured cells (Zhang et al., 1999) . On the other hand, c-myc is known as one of the targets of the estrogen receptor (Shang et al., 2000) . Those observations imply the possibility that Xhmgb3 may be involved in the similar mechanisms of transcription and tumorigenesis. Recently, it was reported that the Notch signaling pathway activates the c-myc promoter in hematopoietic stem cells (Satoh et al., 2004) . In mice hmgb3 is involved in cell proliferation and cell differentiation in hemaopoietic cells (Nemeth et al., 2003 (Nemeth et al., , 2005 . Possibly, Xhmgb3 may have roles in modulating X-Notch-1 function via c-myc regulation in progenitor cells in the CNS. Interestingly, it was recently reported that c-myc is expressed in the CMZ of the retina in zebrafish at late stages (Yamaguchi et al., 2005) .
Together with our findings, we would like to propose the model that rax functions by controlling various factors, including Xhmgb3, XOptx2, Xhairy2 and Zic2, in CNS development and that Xhmgb3 contributes to cell proliferation, at least in part, by modulating the expression of c-myc gene (Fig. 7L) .
